Gene Synthesis Market Size to Reach USD 6.09 Billion by 2031, Supported by Biopharma Demand, Gene Therapy Research, and Faster DNA Synthesis

Mordor Intelligence has published a new report on the Gene Synthesis Market, offering a comprehensive analysis of market trends, growth drivers, segmentation, competitive landscape, and future projections. Hyderabad, India - 7th September 2026, According to Mordor Intelligence, the Gene Synthesis Market size is estimated at USD 2.85 billion in 2026 and is projected to reach USD 6.09 billion by 2031, growing at a CAGR of 16.38% during the forecast period. North America holds the largest market share, while Asia Pacific is expected to register the fastest growth. The market is supported by increasing genomics and next-generation sequencing research, growing demand for synthetic genes from biopharmaceutical companies, government funding for genomics programs, and improvements in DNA synthesis cost and turnaround time. The market is also benefiting from the increasing use of gene synthesis services by pharmaceutical and biotechnology companies seeking faster design and development cycles. Emerging enzymatic DNA synthesis platforms are further supporting demand by offering alternatives to conventional chemical synthesis and helping address requirements for longer and higher-fidelity sequences. Report Overview: https://www.mordorintelligence.com/industry-reports/gene-synthesis-market?utm_source=abnewswire Gene Synthesis Market Trends Growing Demand From Biopharmaceutical Research One of the key Gene Synthesis Market trends is the increasing use of synthetic genes in biopharmaceutical research and development. Pharmaceutical and biotechnology companies use custom DNA sequences across areas such as cell and gene therapy, vaccine development, antibody research, and other therapeutic programs. The growing number of research programs requiring customized genetic constructs is creating demand for providers that can deliver accurate sequences with suitable turnaround times. As biopharmaceutical developers seek to shorten research cycles, outsourced gene synthesis is becoming an important part of laboratory and development workflows. Increasing Use in Gene and Cell Therapy Development Gene and cell therapy development represents an important application area within the Gene Synthesis industry. These therapies require carefully designed genetic sequences for research, development, and manufacturing activities. The growing pipeline of genetic medicines is creating demand for synthetic genes that can support therapeutic research and development. Providers with capabilities for complex sequences, high-fidelity synthesis, and related design services are positioned to serve the requirements of companies developing advanced therapies. Emergence of Enzymatic DNA Synthesis Another important trend influencing the Gene Synthesis Market is the growing interest in enzymatic DNA synthesis. Traditional chemical synthesis continues to have a strong position, particularly for shorter sequences, while enzymatic approaches are gaining attention for their potential to improve synthesis speed, sequence length, and production processes. Enzymatic platforms can also reduce dependence on hazardous chemical solvents and support faster access to synthesized DNA. The development of these platforms is creating additional options for research laboratories and biotechnology companies seeking rapid DNA production. Gene Synthesis Market Segmentation The Gene Synthesis Market is segmented by synthesis method, service type, application, end user, and geography. By Synthesis Method Chemical Oligonucleotide Synthesis Solid-Phase Phosphoramidite Microchip-based Oligonucleotide Synthesis Gene Assembly PCR-mediated Ligation-mediated By Service Type Antibody DNA Synthesis Viral Gene Synthesis Others By Application Gene and Cell Therapy Developments Vaccine Development Disease Diagnosis Others By End User Biopharmaceutical Companies Academic & Government Institutes CROs and CDMOs Others By Geography North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific China Japan India South Korea Australia Rest of Asia-Pacific Middle East and Africa GCC South Africa Rest of Middle East and Africa South America Brazil Argentina Rest of South America The Gene Synthesis Market share varies across regions according to biopharmaceutical activity, genomics research, government funding, biotechnology infrastructure, and demand for synthetic DNA. North America remains the largest regional market, supported by established biopharmaceutical and research capabilities, while Asia Pacific is expected to record the fastest growth as biotechnology investment and genomics activity increase. Gene Synthesis Market Competitive Landscape The competitive landscape of the Gene Synthesis industry includes global life science companies, specialized gene synthesis providers, biotechnology companies, and organizations developing new DNA synthesis platforms. Competition is influenced by sequence accuracy, turnaround time, synthesis capacity, service breadth, and the ability to support complex genetic constructs. Key Players Merck KGaA Eurofins Genomics Thermo Fisher Scientific GenScript Biotech Azenta Life Sciences ATUM Bio Basic Beijing SBS Genetech OriGene Technologies Integrated DNA Technologies Twist Bioscience DNA Script Ansa Biotechnologies Evonetix Telesis Bio Synbio Technologies Bioneer ProteoGenix Bio-Synthesis ATLATL Innovations The market remains moderately concentrated, with leading providers competing through broad gene synthesis portfolios, high-throughput capabilities, sequence quality, and supporting services. Specialized companies are also developing enzymatic and other synthesis approaches that address demand for longer sequences, faster production, and improved synthesis performance. Conclusion The Gene Synthesis Market forecast reflects continued demand for custom DNA as pharmaceutical companies, biotechnology firms, research institutions, and specialized service providers expand their use of synthetic biology and genomics. Increasing biopharmaceutical research, gene and cell therapy development, vaccine research, and disease diagnosis applications are expected to support continued market expansion. Industry Related Reports The Genetic Analysis Market is expected to grow from USD 12.20 billion in 2026 to USD 20.30 billion by 2031, registering a CAGR of 10.69%, driven by declining sequencing costs, expanding clinical reimbursement, national genomics programs, and growing adoption of AI-enabled variant interpretation. https://www.mordorintelligence.com/industry-reports/genetic-analysis-market The Gene Amplification Technologies Market reached USD 29.67 billion in 2025 and is projected to reach USD 34.79 billion by 2030, at a 3.24% CAGR, supported by increasing demand for molecular diagnostics, advancements in PCR-based technologies, and expanding applications across clinical and research settings. https://www.mordorintelligence.com/industry-reports/gene-amplification-technologies-market The DNA Polymerase Market is expected to grow from USD 331.13 million in 2025 to USD 417.91 million by 2030, at a 4.77% CAGR, driven by rising demand for DNA amplification and sequencing workflows, growth in molecular biology research, and expanding applications in biotechnology and diagnostics. https://www.mordorintelligence.com/industry-reports/dna-polymerase-market About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/ Media Contact Company Name: Mordor Intelligence Private Limited Contact Person: Jignesh Thakkar Email: Send Email Phone: +1 617-765-2493 Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli City: Hyderabad State: Telangana 500008 Country: India Website: https://www.mordorintelligence.com/ Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Gene Synthesis Market Size to Reach USD 6.09 Billion by 2031, Supported by Biopharma Demand, Gene Therapy Research, and Faster DNA Synthesis